About iMMCO Diagnostics
iMMCO Diagnostics is a company based in Buffalo (United States) founded in 1971 was acquired by Trinity Biotech in July 2013.. The company has 78 employees as of December 31, 2022. iMMCO Diagnostics operates in a competitive market with competitors including Crescendo Bioscience, Selventa, Cytonics, DNAlytics and Augurex, among others.
- Headquarter Buffalo, United States
- Employees 78 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Immco Diagnostics, Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Trinity Biotech
& 1 more
-
Employee Count
78
as on Dec 31, 2022
-
Acquired by
Trinity Biotech
(Jul 26, 2013)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of iMMCO Diagnostics
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2007 | Amount | Private Equity Round - iMMCO Diagnostics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in iMMCO Diagnostics
iMMCO Diagnostics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Trinity Biotech and Summit Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Summit Partners is recognized as a growth equity investment firm.
|
Founded Year | Domain | Location | |
|
Provider of In vitro diagnostic kits for clinical labs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by iMMCO Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - iMMCO Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Immco Diagnostics Comparisons
Competitors of iMMCO Diagnostics
iMMCO Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Crescendo Bioscience, Selventa, Cytonics, DNAlytics and Augurex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Molecular tests for autoimmune and inflammatory diseases are provided.
|
|
| domain | founded_year | HQ Location |
Selventa specializes in diagnostics for personalized medicine, advancing tailored healthcare solutions.
|
|
| domain | founded_year | HQ Location |
Diagnostics and therapeutics for osteoarthritis are developed.
|
|
| domain | founded_year | HQ Location |
Data-driven personalized medicine is provided from R&D to market access.
|
|
| domain | founded_year | HQ Location |
Diagnostic tests for autoimmune and chronic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about iMMCO Diagnostics
When was iMMCO Diagnostics founded?
iMMCO Diagnostics was founded in 1971 and raised its 1st funding round 36 years after it was founded.
Where is iMMCO Diagnostics located?
iMMCO Diagnostics is headquartered in Buffalo, United States. It is registered at Buffalo, New York, United States.
How many employees does iMMCO Diagnostics have?
As of Dec 31, 2022, the latest employee count at iMMCO Diagnostics is 78.
What does iMMCO Diagnostics do?
IMMCO Diagnostics is a provider of diagnostic solutions for autoimmune disorders. It develops and distributes autoimmune disease diagnostics devices and lab services to the market. Products include IFA ImmuGlo, Mardx, ImmuLisa, Captia (EIA), ImmuBlot, Marstripe, ImmcoStripe (line immunoassays), and Amerlex . The platform offers biopsy, serology, and other test services for the diagnosis of autoimmune disorders and related immunological conditions such as thyroiditis, rheumatoid arthritis, type 1 diabetes, coeliac disease, ulcerative colitis, Crohns disease, systemic lupus erythematosus, and scleroderma systemic sclerosis. It also provides diagnostic solutions for infectious disease, hemoglobins, autoimmune, antibodies, urinalysis, and more.
Who are the top competitors of iMMCO Diagnostics?
iMMCO Diagnostics's top competitors include Cytonics, Crescendo Bioscience and Augurex.
Who are iMMCO Diagnostics's investors?
iMMCO Diagnostics has 2 investors. Key investors include Trinity Biotech, and Summit Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.